Taysha Gene Therapies Inc (TSHA)
3.09
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
3.09
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Accounts Payable (Quarterly): 10.38M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 10.38M |
December 31, 2023 | 6.366M |
September 30, 2023 | 7.52M |
June 30, 2023 | 10.77M |
March 31, 2023 | 9.002M |
December 31, 2022 | 10.95M |
September 30, 2022 | 15.25M |
June 30, 2022 | 23.97M |
Date | Value |
---|---|
March 31, 2022 | 22.00M |
December 31, 2021 | 21.76M |
September 30, 2021 | 22.05M |
June 30, 2021 | 6.355M |
March 31, 2021 | 4.083M |
December 31, 2020 | 1.994M |
September 30, 2020 | 8.837M |
June 30, 2020 | 1.25M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.25M
Minimum
Jun 2020
23.97M
Maximum
Jun 2022
11.41M
Average
9.691M
Median
Accounts Payable (Quarterly) Benchmarks
Aquestive Therapeutics Inc | 10.52M |
Lifecore Biomedical Inc | 22.14M |
Relmada Therapeutics Inc | 5.189M |
ACADIA Pharmaceuticals Inc | 19.33M |
Cyclacel Pharmaceuticals Inc | 5.20M |